Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Imodium consumer lawsuit

This article was originally published in The Tan Sheet

Executive Summary

Proposed class action filed on behalf of retail purchasers of Imodium Advanced asserts claims for unlawful monopoly, unfair trade practices, unjust enrichment against McNeil. Filed in Philadelphia federal court July 2, complaint alleges J&J division unlawfully extended patent protection for loperamide/simethicone combination through improper patent filings, denying consumers access to lower-priced generic alternatives. Complaint filed by members of Prescription Access Litigation project marks PAL's first lawsuit involving an OTC drug. Case is assigned to Judge Berle Schiller, who last month declared McNeil's patent claims invalid (1"The Tan Sheet" July 1, 2002, p. 3). McNeil calls PAL lawsuit "baseless," notes product faces substantial generic competition in anti-diarrheal market...
Advertisement

Related Content

McNeil Imodium Patent Prosecution Conduct Leads To Perrigo Fee Award
McNeil Imodium Patent Prosecution Conduct Leads To Perrigo Fee Award

Topics

Advertisement
UsernamePublicRestriction

Register

PS094272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel